Table 2B.
Water corrected mean metabolite levels at baseline in ACC and thalamus in UHR with remission, non-remission, or transition group at 12-months follow-up
| ACC | Left thalamus | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Remission | Non-remission | Transition | One-Way ANOVA | Remission | Non-remission | Transition | One-Way ANOVA | ||
| Glu | 9.39±0.89 (N = 25) |
9.11±0.76 (N = 41) |
9.47±0.60 (N = 13) |
0.22 | 6.49±1.09 (N = 22) |
6.50±0.70 (N = 36) |
6.52±0.75 (N = 11) |
0.99 | |
| Glx | 12.46±1.27 (N = 25) |
12.17±1.27 (N = 41) |
12.71±1.03 (N = 13) |
0.35 | 9.13±1.55 (N = 22) |
9.03±1.06 (N = 36) |
9.23±1.28 (N = 11) |
0.89 | |
| GABA | 2.18 ±0.25 (N = 24) |
2.20 ±0.23 (N = 35) |
2.21 ±0.23 (N = 11) |
0.57 | - | - | - | - | |
Abbreviations: ACC, Anterior cingulate cortex; UHR, Ultra-high risk; Glu, Glutamate; Glx, glutamate+glutamine; GABA, Gamma-aminobutyric acid